2篇
您的检索式：作者名="REHAB M.AMEN"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Investigation of the antioxidant defensive role of both AD-MSCs and BM-MSCs in modulating the alteration in the oxidative stress status in various STZ-diabetic rats’tissues显示文摘Diabetes mellitus(DM)could negatively affect patients’health via inducing a lot of serious functional hazards in many tissues’cells at molecular levels.Recently,many scientists had proposed stem cell therapy being an appropriate alternative treatment protocol for numerous health threatening issues including diabetes.Therefore,the current study was designed to investigate the antioxidant potentiality of two MSCs types in alleviating tissues’oxidative stress dramatic elevation resulting as a consequence of Type 1 DM induction.In our 4 weeks study,animals were divided into four groups:control group,STZ-diabetic group(D),D+AD-MSCs group and D+BM-MSCs group.Data reported that diabetic rats treated with either AD-MSCs or BM-MSCs exhibited a marvelous body tissues(Pancreas,Liver and Kidney)enhancing capabilities in attenuating the oxidative stress status;as evidenced by XO,ROS,and MDA levels down-regulation;with a general concomitant elevation in the antioxidants’content;evidenced by many enzymatic and non-enzymatic antioxidants up-regulation;relative to the diabetic untreated group.Interestingly,comparing both treatments with each other and to control group,most of the measured parameters were reverted back to near normal levels after AD-MSCs injection;which clearly point out their stunning health benefits and superiority as anti-diabetic agent in overcoming different tissues’complications;owing to their marked cytoprotective and regenerative potentialities. | SHADY G.EL-SAWAH FAYEZ ALTHOBAITI ADIL ALDHAHRANI EMAN FAYAD MARWA A.ABDEL-DAYEM REHAB M.AMEN EL SHAIMAA SHABANA EHAB I.EL-HALLOUS HANAN M.RASHWAN | 2021 | BIOCELL2021，45，6： | 0 |
| 2 | Anti-inflammatory and antioxidant potential capacities of AD-MSCs and BM-MSCs in suppressing pancreaticβ-cells auto-immunity and apoptosis in rats with T1DM induced model显示文摘Since Type 1 diabetes(T1DM)occurs whenβ-cells mass is reduced to less than 20%of the normal level due to autoimmune destruction of cells resulting in the inability to secrete insulin,preservation or replenishment of the functionalβ-cells mass has become a major therapeutic focus for this diabetic type treatment.Thus,this 4-week work plan was designed to determine which mesenchymal stem cells(MSCs)type is more appropriate to alleviate pancreatic hazards resulting from diabetes induction;via tracking a comparative study between MSCs derived from adipose tissue(AD-MSCs)and from bone marrow(BM-MSCs)in management of T1DM considering their immunomodulatory,anti-apoptotic and antioxidative roles.Rats were divided randomly into 4 groups;control,STZdiabetic(D),D+AD-MSCs,and D+BM-MSCs groups.Both stem cells types in this study were allogenic.Herein,both oxidative stress and antioxidant markers were evaluated using colorimetric analysis,while inflammatory,immune and apoptotic markers were assessed through flow cytometric analysis.Results showed that diabetic rats treated with either AD-MSCs or BM-MSCs exhibited marked pancreatic antioxidant and anti-inflammatory activities that were able to initiate pancreatic immunomodulation and reducingβ-cells apoptotic death,thus,help to restore their normal insulin secretion and hypoglycemic abilities.However,AD-MSCs injection was shown to be superior as a pancreatic regenerative tool in overcoming diabetes;owing to their marked antioxidant,anti-inflammatory,immunomodulatory,and anti-apoptotic characteristics over BM-MSCs treatment. | SHADY G.EL-SAWAH FAYEZ ALTHOBAITI HANAN M.RASHWAN ADIL ALDHAHRANI MARWA A.ABDEL-DAYEM EMAN FAYAD REHAB M.AMEN EL SHAIMAA SHABANA EHAB I.EL-HALLOUS | 2022 | BIOCELL2022，46，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员